Q: What equation describes reversible protein-ligand binding?
A: The equilibrium equation with dissociation constant (Kd) and association constant (Ka).
Q: How is fractional occupancy (Y or θ) defined?
A: Fraction of protein P that exists in a protein-ligand complex (PL) divided by the total protein (P + PL).
Q: How can you determine Kd experimentally?
A: By plotting Y (fraction bound) vs. ligand concentration [L].
Q: What are the structural differences between myoglobin (Mb) and hemoglobin (Hb)?
A: Mb is a monomer with 1 heme and 1 O₂ binding site, while Hb is a tetramer with 4 hemes and 4 O₂ binding sites.
Q: What is the role of the heme group in oxygen binding?
A: It contains Fe²⁺, which binds O₂ reversibly in a stable oxidation state.
Q: What is the role of histidine residues in oxygen binding?
A: Proximal His F8 coordinates Fe²⁺, while distal His E7 stabilizes bound O₂.
Q: What is the Hill coefficient (nH), and what does it indicate?
A: nH describes the degree of cooperativity in ligand binding:
nH = 1 (no cooperativity)
nH > 1 (positive cooperativity)
nH < 1 (negative cooperativity)
Q: What is the difference between the T and R states of hemoglobin?
A:
T (tense) state: More interactions, more stable, lower O₂ affinity.
R (relaxed) state: Fewer interactions, more flexible, higher O₂ affinity.
Q: What triggers the T → R conformational change?
A: O₂ binding breaks ion pairs at the α1-β2 interface, increasing O₂ affinity.
Q: What is an allosteric modulator?
A: A molecule that influences protein function by binding at a site other than the active site.
Q: What are examples of positive and negative allosteric effectors of Hb?
A:
Positive effectors: O₂ (homotropic), CO (heterotropic).
Negative effectors: 2,3-BPG, CO₂, H⁺ (heterotropic).
Q: How does CO binding affect hemoglobin function?
A: CO binds to Fe²⁺ ~20,000x better than O₂ (in free heme) and 40x better in Mb/Hb, increasing O₂ affinity but preventing its release.
Q: Why is CO poisoning dangerous?
A: Hb with bound CO does not release O₂ effectively, leading to tissue hypoxia.
Q: How does 2,3-BPG affect hemoglobin?
A: Binds in the central cavity of Hb, stabilizing the T-state and promoting O₂ release.
Q: How does altitude affect 2,3-BPG levels?
A: Higher altitudes increase 2,3-BPG levels, enhancing O₂ unloading in tissues.
Q: What is the Bohr effect?
A: A decrease in pH (increase in H⁺ or CO₂) lowers Hb’s O₂ affinity, promoting O₂ release in tissues.
Q: How does CO₂ bind to hemoglobin?
A: Forms carbaminohemoglobin by reacting with N-terminal amino groups, stabilizing the T-state.
Q: What mutation causes sickle-cell anemia?
A: Glutamate (E) → Valine (V) substitution at position 6 in the β chain of Hb.
Q: How does the E6V mutation affect red blood cells?
A: Causes Hb polymerization, leading to rigid, sickle-shaped cells that block capillaries.
Q: What are the two main branches of the adaptive immune system?
A:
Humoral immunity: B cells produce antibodies that recognize antigens.
Cell-mediated immunity: T cells directly attack infected cells.
Q: What are the components of an antibody (immunoglobulin)?
A:
Y-shaped structure with heavy and light chains.
Two antigen-binding sites formed by variable domains.
Q: What is an epitope?
A: The specific region on an antigen that an antibody recognizes and binds to.
Q: How does antibody diversity arise?
A: Through genetic recombination of immunoglobulin gene segments.
Q: What equation describes reversible protein-ligand binding?
A: The equilibrium equation with constants for ligand dissociation (Kd) and association (Ka).
Q: How is fractional occupancy (Y or θ) defined?
A: Fraction of protein (P) that exists in a protein-ligand complex (PL) divided by total protein (P + PL).
Q: How can Kd be determined experimentally?
A: By plotting Y (fraction bound) vs. ligand concentration [L].
Q: What is the structural difference between myoglobin (Mb) and hemoglobin (Hb)?
A:
Mb: Monomer with 1 heme and 1 O₂ binding site.
Hb: Tetramer with 4 hemes and 4 O₂ binding sites.
Q: What is the role of histidine residues in oxygen binding?
A:
Proximal His F8 coordinates Fe²⁺.
Distal His E7 stabilizes bound O₂.
Q: How does Fe²⁺ contribute to O₂ binding?
A: Fe²⁺ in the heme group binds O₂ reversibly in a stable oxidation state.
Q: What is the difference between the T and R states of hemoglobin?
A:
T (tense) state: More interactions, stable, low O₂ affinity.
R (relaxed) state: Fewer interactions, flexible, high O₂ affinity.
Q: What is the Hill coefficient (nH), and what does it indicate?
A:
nH = 1: No cooperativity.
nH > 1: Positive cooperativity (e.g., Hb).
nH < 1: Negative cooperativity.
Q: What effect does O₂ binding have on hemoglobin structure?
A: O₂ binding shifts Fe²⁺ into the plane of the porphyrin ring, triggering T → R transition.
Q: What are examples of allosteric effectors of Hb?
A:
Positive effectors: O₂ (homotropic), CO (heterotropic).
Negative effectors: 2,3-BPG, CO₂, H⁺ (heterotropic).
Q: What is the Bohr effect?
A: A decrease in pH (increase in H⁺ or CO₂) lowers Hb’s O₂ affinity, promoting O₂ release in tissues.
Q: How does 2,3-BPG affect Hb function?
A:
Binds the central cavity of Hb.
Stabilizes the T-state.
Enhances O₂ release at high altitudes.
Q: How does CO poisoning affect Hb function?
A:
CO binds to Fe²⁺ ~40x better than O₂ in Hb.
Increases O₂ affinity but prevents O₂ release.
Leads to tissue hypoxia.
Q: What are antibodies (Abs)?
A: Immune system proteins that recognize and neutralize foreign molecules.
Q: What is the general structure of an antibody?
A:
4 polypeptide chains (2 heavy, 2 light).
"Y"-shaped quaternary structure.
Antigen-binding sites at the tips of the arms.
Q: What are the key regions of an antibody?
A:
Variable (V) domains: Bind antigens.
Constant (C) domains: Interact with immune cells.
Complementarity Determining Region (CDR): Recognizes specific epitopes.
Q: How are antibodies held together?
A: By disulfide bonds between chains.
Q: What are the five antibody isotypes?
A:
IgG: Most abundant, secondary immune response.
IgA: Mucosal immunity (saliva, tears, gut lining).
IgM: First produced, pentameric structure.
IgE: Involved in allergic reactions.
IgD: Function not well understood.
Q: How does IgG activate the immune response?
A:
Binds pathogens.
Activates macrophages via Fc receptor binding.
Promotes phagocytosis.
Q: What forces mediate antibody-antigen binding?
A:
Van der Waals forces
Hydrophobic interactions
Dipole interactions
Hydrogen bonds
Q: What is the induced fit model in antibody binding?
A: Both the antigen and antibody undergo conformational changes upon binding.
Q: What is a hapten?
A: A small molecule that is non-immunogenic alone but elicits an immune response when attached to a larger protein.
Q: How is antibody diversity generated?
A:
V(D)J recombination: DNA rearrangement of immunoglobulin genes.
Hypermutation: Introduces additional variability in binding sites.
Q: What is immunological memory?
A: The ability of the immune system to remember and respond quickly to previously encountered pathogens.